Cellosaurus logo
expasy logo

Cellosaurus DR177 (CVCL_A1YN)

[Text version]
Cell line name DR177
Accession CVCL_A1YN
Resource Identification Initiative To cite this cell line use: DR177 (RRID:CVCL_A1YN)
Comments Population: Caucasian.
Doubling time: 32.9 hours (PubMed=24443327).
Derived from site: In situ; Brain; UBERON=UBERON_0000955.
Disease Glioblastoma (NCIt: C3058)
Glioblastoma (ORDO: Orphanet_360)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 68Y
Category Cancer cell line
Publications

PubMed=22257080; DOI=10.1111/j.1750-3639.2012.00566.x; PMCID=PMC8057648
Raso A., Vecchio D., Cappelli E., Ropolo M., Poggi A., Nozza P., Biassoni R., Mascelli S., Capra V., Kalfas F., Severi P., Frosina G.
Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.
Brain Pathol. 22:677-688(2012)

PubMed=24443327; DOI=10.1002/ijc.28680
Vecchio D., Daga A., Carra E., Marubbi D., Baio G., Neumaier C.E., Vagge S., Corvo R., Brisigotti M.P., Ravetti J.L., Zunino A., Poggi A., Mascelli S., Raso A., Frosina G.
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.
Int. J. Cancer 135:479-491(2014)

Cross-references
Encyclopedic resources Wikidata; Q105506769
Entry history
Entry creation12-Jan-2021
Last entry update29-Jun-2023
Version number4